Abstract

Microbiome-derived Gram-negative bacterial lipopolysaccharide (LPS) has been shown by multiple laboratories to reside within Alzheimer's disease (AD)-affected neocortical and hippocampal neurons. LPS and other pro-inflammatory stressors strongly induce a defined set of NF-kB (p50/p65)-sensitive human microRNAs, including a brain-enriched microRNA-30b-5p (hsa-miRNA-30b-5p; miRNA-30b). Here we provide evidence that this neuropathology-associated miRNA, known to be upregulated in AD brain and LPS-stressed human neuronal-glial (HNG) cells in primary culture targets the neurofilament light (NF-L) chain mRNA 3'-untranslated region (3'-UTR), which is conducive to the post-transcriptional downregulation of NF-L expression observed within both AD and LPS-treated HNG cells. A deficiency of NF-L is associated with consequent atrophy of the neuronal cytoskeleton and the disruption of synaptic organization. Interestingly, miRNA-30b has previously been shown to be highly expressed in amyloid-beta (Aβ) peptide-treated animal and cell models, and Aβ peptides promote LPS entry into neurons. Increased miRNA-30b expression induces neuronal injury, neuron loss, neuronal inflammation, impairment of synaptic transmission, and synaptic failure in neurodegenerative disease and transgenic murine models. This gut microbiota-derived LPS-NF-kB-miRNA-30b-NF-L pathological signaling network: underscores a positive pathological link between the LPS of gastrointestinal (GI)-tract microbes and the inflammatory neuropathology, disordered cytoskeleton, and disrupted synaptic signaling of the AD brain and stressed brain cells; and is the first example of a microbiome-derived neurotoxic glycolipid having significant detrimental miRNA-30b-mediated actions on the expression of NF-L, an abundant neuron-specific filament protein known to be important in the maintenance of neuronal cell shape, axonal caliber, and synaptic homeostasis.

MeSH

Neurons, Brain, Cells, Neuroglia, Cytoskeleton, 3' Untranslated Regions, Lipopolysaccharides, Micrornas, Nf-Kappa B, Down-Regulation

Cited by

• Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence. Neural Regen Res, 2023
• Role of Antioxidants in Modulating the Microbiota-Gut-Brain Axis and Their Impact on Neurodegenerative Diseases. Int J Mol Sci, 2025
• Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy. J Inflamm Res, 2023
• Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases. Behav Neurol, 2023
• The intersection between circulatory microRNAs and biomarkers of neurodegeneration. Alzheimers Res Ther, 2025
• Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer's Disease (AD). Int J Mol Sci, 2022
• Polyphenols and miRNA interplay: a novel approach to combat apoptosis and inflammation in Alzheimer's disease. Front Aging Neurosci, 2025